TGF-β regulation of gene expression at early and late stages of HPV16-mediated transformation of human keratinocytes

Virology

Volumn 447, Issue 1-3, 2013, Pages 63-73

  Kowli, Sangeeta ^a   Velidandla, Rupa ^b   Creek, Kim E ^b   Pirisi, Lucia ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

EMT; HPV; Human keratinocytes; Ski; Smad; TGF beta

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN;

ARTICLE; CELL CYCLE PHASE; CELL IMMORTALIZATION; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOSKELETON; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; KERATINOCYTE; MICROARRAY ANALYSIS; NONHUMAN; PRECANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL;

EMT; HPV; HUMAN KERATINOCYTES; SKI; SMAD; TGF-BETA;

CELL LINE; CELL TRANSFORMATION, VIRAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; KERATINOCYTES; MICROARRAY ANALYSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84884326165     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.08.034     Document Type: Article

References (61)

1. Baldwin A., Pirisi L., Creek K.E. NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression. J. Virol. 2004, 78:3953-3964.
2. Batova A., Danielpour D., Pirisi L., Creek K.E. Retinoic acid induces secretion of latent transforming growth factor beta 1 and beta 2 in normal and human papillomavirus type 16-immortalized human keratinocytes. Cell Growth Differ.: Mol. Biol. J. Am. Assoc. Cancer Res. 1992, 3:763-772.
3. Bernat A., Avvakumov N., Mymryk J.S., Banks L. Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300. Oncogene 2003, 22:7871-7881.
4. Bheda A., Creek K.E., Pirisi L. Loss of p53 induces epidermal growth factor receptor promoter activity in normal human keratinocytes. Oncogene 2008, 27:4315-4323.
5. Bhowmick N.A., Ghiassi M., Bakin A., Aakre M., Lundquist C.A., Engel M.E., Arteaga C.L., Moses H.L. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell 2001, 12:27-36.
6. Borger D.R., Mi Y., Geslani G., Zyzak L.L., Batova A., Engin T.S., Pirisi L., Creek K.E. Retinoic acid resistance at late stages of human papillomavirus type 16-mediated transformation of human keratinocytes arises despite intact retinoid signaling and is due to a loss of sensitivity to transforming growth factor-beta. Virology 2000, 270:397-407.
7. Bruewer M., Hopkins A.M., Hobert M.E., Nusrat A., Madara J.L. RhoA, Rac1, and Cdc42 exert distinct effects on epithelial barrier via selective structural and biochemical modulation of junctional proteins and F-actin. Am. J. Physiol.: Cell Physiol. 2004, 287:C327-335.
8. Chen Y., Pirisi L., Creek K.E. Ski protein levels increase during in vitro progression of HPV16-immortalized human keratinocytes and in cervical cancer. Virology 2013, 444:100-108.
9. Chuang P.Y., Menon M.C., He J.C. Molecular targets for treatment of kidney fibrosis. J. Mol. Med. 2013, 91:549-559.
10. Creek K.E., Geslani G., Batova A., Pirisi L. Progressive loss of sensitivity to growth control by retinoic acid and transforming growth factor-beta at late stages of human papillomavirus type 16-initiated transformation of human keratinocytes. Adv. Exp. Med. Biol. 1995, 375:117-135.
11. Creek K.E., Jenkins G.R., Khan M.A., Batova A., Hodam J.R., Tolleson W.H., Pirisi L. Retinoic acid suppresses human papillomavirus type 16 (HPV16)-mediated transformation of human keratinocytes and inhibits the expression of the HPV16 oncogenes. Adv. Exp. Med. Biol. 1994, 354:19-35.
12. Dai J.L., Turnacioglu K.K., Schutte M., Sugar A.Y., Kern S.E. Dpc4 transcriptional activation and dysfunction in cancer cells. Cancer Res. 1998, 58:4592-4597.
13. Dawes L.J., Elliott R.M., Reddan J.R., Wormstone Y.M., Wormstone I.M. Oligonucleotide microarray analysis of human lens epithelial cells: TGFbeta regulated gene expression. Mol. Vision 2007, 13:1181-1197.
14. DiPaolo J.A., Woodworth C.D., Popescu N.C., Koval D.L., Lopez J.V., Doniger J. HSV-2-induced tumorigenicity in HPV16-immortalized human genital keratinocytes. Virology 1990, 177:777-779.
15. DiPaolo J.A., Woodworth C.D., Popescu N.C., Notario V., Doniger J. Induction of human cervical squamous cell carcinoma by sequential transfection with human papillomavirus 16 DNA and viral Harvey ras. Oncogene 1989, 4:395-399.
16. Edlund S., Landstrom M., Heldin C.H., Aspenstrom P. Transforming growth factor-beta-induced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Mol. Biol. Cell 2002, 13:902-914.
17. Ewing C.M., Ru N., Morton R.A., Robinson J.C., Wheelock M.J., Johnson K.R., Barrett J.C., Isaacs W.B. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function. Cancer Res. 1995, 55:4813-4817.
18. Fera D., Marmorstein R. Different regions of the HPV-E7 and Ad-E1A viral oncoproteins bind competitively but through distinct mechanisms to the CH1 transactivation domain of p300. Biochemistry 2012, 51:9524-9534.
19. Frolik C.A., Wakefield L.M., Smith D.M., Sporn M.B. Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. J. Biol. Chem. 1984, 259:10995-11000.
20. Fukawa T., Kajiya H., Ozeki S., Ikebe T., Okabe K. Reactive oxygen species stimulates epithelial mesenchymal transition in normal human epidermal keratinocytes via TGF-beta secretion. Exp. Cell Res. 2012, 318:1926-1932.
21. Garamszegi N., Garamszegi S.P., Shehadeh L.A., Scully S.P. Extracellular matrix-induced gene expression in human breast cancer cells. Mol. Cancer Res. 2009, 7:319-329.
22. Habig M., Smola H., Dole V.S., Derynck R., Pfister H., Smola-Hess S. E7 proteins from high- and low-risk human papillomaviruses bind to TGF-beta-regulated Smad proteins and inhibit their transcriptional activity. Arch. Virol. 2006, 151:1961-1972.
23. Hellner K., Mar J., Fang F., Quackenbush J., Munger K. HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition. Virology 2009, 391:57-63.
24. Hsu S., Huang F., Hafez M., Winawer S., Friedman E. Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression. Cell Growth Differ. 1994, 5:267-275.
25. Hypes M.K., Pirisi L., Creek K.E. Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation. Cancer Lett. 2009, 282:177-186.
26. Kalluri R., Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 2003, 112:1776-1784.
27. Kang Y., Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004, 118:277-279.
28. Kasai H., Allen J.T., Mason R.M., Kamimura T., Zhang Z. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir. Res. 2005, 6:56.
29. Kaur P., McDougall J.K. Characterization of primary human keratinocytes transformed by human papillomavirus type 18. J. Virol. 1988, 62:1917-1924.
30. Khalil N., Parekh T.V., O'Connor R., Antman N., Kepron W., Yehaulaeshet T., Xu Y.D., Gold L.I. Regulation of the effects of TGF-beta 1 by activation of latent TGF-beta 1 and differential expression of TGF-beta receptors (T beta R-I and T beta R-II) in idiopathic pulmonary fibrosis. Thorax 2001, 56:907-915.
31. Kurisaki K., Kurisaki A., Valcourt U., Terentiev A.A., Pardali K., Ten Dijke P., Heldin C.H., Ericsson J., Moustakas A. Nuclear factor YY1 inhibits transforming growth factor beta- and bone morphogenetic protein-induced cell differentiation. Mol. Cell. Biol. 2003, 23:4494-4510.
32. Lee D.K., Kim B.C., Kim I.Y., Cho E.A., Satterwhite D.J., Kim S.J. The human papilloma virus E7 oncoprotein inhibits transforming growth factor-beta signaling by blocking binding of the Smad complex to its target sequence. J. Biol. Chem. 2002, 277:38557-38564.
33. Lee M.Y., Chou C.Y., Tang M.J., Shen M.R. Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation. Clin. Cancer Res. 2008, 14:4743-4750.
34. Massague J. TGFbeta in cancer. Cell 2008, 134:215-230.
35. Massague J., Blain S.W., Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000, 103:295-309.
36. Massague J., Gomis R.R. The logic of TGFbeta signaling. FEBS Lett. 2006, 580:2811-2820.
37. Mi Y., Borger D.R., Fernandes P.R., Pirisi L., Creek K.E. Loss of transforming growth factor-beta (TGF-beta) receptor type I mediates TGF-beta resistance in human papillomavirus type 16-transformed human keratinocytes at late stages of in vitro progression. Virology 2000, 270:408-416.
38. Miettinen P.J., Ebner R., Lopez A.R., Derynck R. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J. Cell Biol. 1994, 127:2021-2036.
39. Munger K., Werness B.A., Dyson N., Phelps W.C., Harlow E., Howley P.M. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 1989, 8:4099-4105.
40. Oft M., Heider K.H., Beug H. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol. 1998, 8:1243-1252.
41. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
42. Pirisi L., Creek K.E., Doniger J., DiPaolo J.A. Continuous cell lines with altered growth and differentiation properties originate after transfection of human keratinocytes with human papillomavirus type 16 DNA. Carcinogenesis 1988, 9:1573-1579.
43. Pirisi L., Yasumoto S., Feller M., Doniger J., DiPaolo J.A. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J. Virol. 1987, 61:1061-1066.
44. Pouponnot C., Jayaraman L., Massague J. Physical and functional interaction of SMADs and p300/CBP. J. Biol. Chem. 1998, 273:22865-22868.
45. Rey O., Lee S., Park N.H. Human papillomavirus type 16 E7 oncoprotein represses transcription of human fibronectin. J. Virol. 2000, 74:4912-4918.
46. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63:1129-1136.
47. Seoane J. Escaping from the TGFbeta anti-proliferative control. Carcinogenesis 2006, 27:2148-2156.
48. Shipley G.D., Pittelkow M.R., Wille J.J., Scott R.E., Moses H.L. Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium. Cancer Res. 1986, 46:2068-2071.
49. Sui G., Affar el B., Shi Y., Brignone C., Wall N.R., Yin P., Donohoe M., Luke M.P., Calvo D., Grossman S.R., Shi Y. Yin Yang 1 is a negative regulator of p53. Cell 2004, 117:859-872.
50. Ten Dijke P., Goumans M.J., Itoh F., Itoh S. Regulation of cell proliferation by Smad proteins. J. Cell. Physiol. 2002, 191:1-16.
51. Thiery J.P. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opinion Cell Biol. 2003, 15:740-746.
52. Uemura M., Swenson E.S., Gaca M.D., Giordano F.J., Reiss M., Wells R.G. Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization. Mol. Biol. Cell 2005, 16:4214-4224.
53. Vaccarella, S., Lortet-Tieulent, J., Plummer, M., Franceschi, S., Bray, F., 2013. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors, Eur. J. Cancer 2013 Jun 7. pii: S0959-8049(13)00358-4. [Epub ahead of print]. http://dx.doi.org/10.1016/j.ejca.2013.04.024.
54. Vardouli L., Vasilaki E., Papadimitriou E., Kardassis D., Stournaras C. A novel mechanism of TGFbeta-induced actin reorganization mediated by Smad proteins and Rho GTPases. FEBS J. 2008, 275:4074-4087.
55. Wendt M.K., Tian M., Schiemann W.P. Deconstructing the mechanisms and consequences of TGF-beta-induced EMT during cancer progression. Cell Tissue Res. 2012, 347:85-101.
56. Wu Y., Zhou B.P. New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim. Biophys. Sin. (Shanghai) 2008, 40:643-650.
57. Yang J., Weinberg R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 2008, 14:818-829.
58. Yao H.W., Xie Q.M., Chen J.Q., Deng Y.M., Tang H.F. TGF-beta1 induces alveolar epithelial to mesenchymal transition in vitro. Life Sci. 2004, 76:29-37.
59. Zavadil J., Bottinger E.P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005, 24:5764-5774.
60. Zhang Y.E. Non-Smad pathways in TGF-beta signaling. Cell Res. 2009, 19:128-139.
61. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 2000, 92:690-698.